AstraZeneca's Brilinta Approved With Aspirin Warning
This article was originally published in The Pink Sheet Daily
Executive Summary
Anti-platelet ticagrelor carries a boxed warning that concomitant aspirin dose must be limited to 100 mg/day, a departure for U.S. prescribers accustomed to high-dose aspirin therapy.